Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001991885 | SCV002277582 | uncertain significance | not provided | 2021-08-15 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals affected with ADCY10-related conditions. This variant is present in population databases (rs368942743, ExAC 0.001%). This sequence change replaces phenylalanine with serine at codon 1249 of the ADCY10 protein (p.Phe1249Ser). The phenylalanine residue is highly conserved and there is a large physicochemical difference between phenylalanine and serine. |
Fulgent Genetics, |
RCV002486602 | SCV002783079 | uncertain significance | Familial idiopathic hypercalciuria | 2021-11-24 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004045498 | SCV003603888 | uncertain significance | not specified | 2021-12-20 | criteria provided, single submitter | clinical testing | The c.3746T>C (p.F1249S) alteration is located in exon 26 (coding exon 25) of the ADCY10 gene. This alteration results from a T to C substitution at nucleotide position 3746, causing the phenylalanine (F) at amino acid position 1249 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |